Genolution is a leading brand that has been revolutionizing the fields of molecular diagnostics and RNAi since its establishment in 2006. With a commitment to providing better quality and better solutions, they have developed advanced nucleic acid extraction platforms and extraction kits under the Nextractor® series. These cutting-edge technologies have played a crucial role in molecular diagnostics, genetic testing, and life sciences research.

Additionally, Genolution's expertise in double-stranded RNA (dsRNA) synthesis has allowed them to supply researchers with large-scale dsRNA for gene expression studies and pest control product development. With partnerships spanning academia, government institutes, reference labs, and industry leaders worldwide, Genolution has become a trusted name in the industry. Their accountability and transparency are further exemplified by their status as a publicly listed company.

Operated by a diverse team of experts, including CEO Gi Ok Kim, CTO Minlee Kim, and CFO Jaehyung Choi, Genolution continues to strive for excellence in providing innovative solutions for a better life. Specializing in IVD medical instruments for molecular diagnostics, they also offer RNAi-related products and services, supporting advancements in RNAi research and development. Discover the better quality and better solutions that Genolution brings to the world of molecular diagnostics and RNAi